not tagged
not tagged
['hfpef']
 at 2022 drug prices, adding an sglt2-i to standard of care was of intermediate or low economic value compared with standard of care in us adults with hfpef. #acc23 does that change your practice ?
Physician-scientist, Interventional Cardiologist @MGHMedicine @HarvardMed @BroadInstitute | genomics, coronary artery disease, healthcare innovation